- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2202
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapeutic potential of resveratrol in Alzheimer's disease ; volume:9 ; number:2 ; day:3 ; month:12 ; year:2008 ; pages:1-5 ; date:12.2008
BMC neuroscience ; 9, Heft 2 (3.12.2008), 1-5, 12.2008
- Creator
-
Vingtdeux, Valérie
- Contributor
-
Dreses-Werringloer, Ute
Zhao, Haitian
Davies, Peter
Marambaud, Philippe
SpringerLink (Online service)
- DOI
-
10.1186/1471-2202-9-S2-S6
- URN
-
urn:nbn:de:1111-2016032059673
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vingtdeux, Valérie
- Dreses-Werringloer, Ute
- Zhao, Haitian
- Davies, Peter
- Marambaud, Philippe
- SpringerLink (Online service)
Other Objects (12)
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Alzheimer disease : therapeutic strategies
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease
Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease
Potential terahertz therapeutic strategy for the prevention or mitigation of Alzheimer’s disease pathology
Perispinal etanercept: Potential as an Alzheimer therapeutic
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Alzheimer disease : therapeutic strategies
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease
Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease
Potential terahertz therapeutic strategy for the prevention or mitigation of Alzheimer’s disease pathology
Perispinal etanercept: Potential as an Alzheimer therapeutic
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Alzheimer disease : therapeutic strategies
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease
Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease
Potential terahertz therapeutic strategy for the prevention or mitigation of Alzheimer’s disease pathology